![]() |
市場調查報告書
商品編碼
1913389
培養肉市場:市場機會、成長促進因素、產業趨勢分析及預測(2026-2035)Cultured Meat Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球培養肉市場預計到 2025 年將達到 12 億美元,到 2035 年將達到 274 億美元,年複合成長率為 36.3%。

培養肉反應器是培養肉產業的核心,它提供了一種可擴展的解決方案,無需屠宰動物即可生產實驗室培養肉。這些生物反應器為動物細胞培養創造了精確的環境,從而實現對細胞生長、營養輸送和壓力管理的精準控制。不同的系統,包括攪拌槽、灌注式、氣升和中空纖維式生物反應器,在擴充性和細胞維護方面各具優勢。生物反應器設計、培養基最佳化和放大技術的最新創新,使得經濟高效的大規模生產成為可能。隨著時間的推移,技術進步有望降低生產成本,提高培養肉的可負擔性和普及性。人造肉質、風味和品質的提升也將推動消費者接受度,並促進市場擴張。日益成長的倫理、環境和永續性問題,以及對肉類替代品需求的不斷成長,是推動該市場發展的關鍵因素。
| 市場覆蓋範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 初始市場規模 | 12億美元 |
| 市場規模預測 | 274億美元 |
| 複合年成長率 | 36.3% |
永續性是培養肉生物反應器市場的關鍵促進因素。實驗室培育肉類為傳統肉類生產提供了一種對環境友善且符合倫理的替代方案,並符合不斷變化的消費者偏好。然而,高昂的初始資本和營運成本構成了挑戰,尤其對於Start-Ups公司和新興企業,儘管市場潛力巨大,但仍會阻礙其商業化進程。
預計到2025年,碎肉製品將佔據最大市場佔有率,達到9.018億美元。這些培養肉之所以能引領市場,是因為與擠壓肉塊相比,它們的生產流程更簡單,規模化生產速度更快。由於其易於組織形成,製造商可以在較小的生物反應器中進行操作,而不會影響質地或感官品質。此外,它們用途廣泛,可用於製作漢堡、肉丸、餃子和雞塊等各種流行食品,因此越來越受到消費者的青睞。這種相容性使生產商能夠瞄準那些能夠承受較高初始價格的大消費群體,同時保持可預測的需求模式。
預計到2025年,人類食品領域的市場規模將達到8.417億美元。以人類消費為重點是培養肉產業發展的主要動力,各公司優先開發符合主流飲食習慣和商業食品服務需求的產品。試吃活動、早期監管核准和有限的零售推廣主要面向人類消費,使公司能夠更大規模地檢驗產品的口味、質地和安全性。這種策略符合永續性和倫理的蛋白質趨勢,有助於將培養肉確立為傳統動物性產品的可行替代品。
美國在北美培養肉市場佔據主導地位,預計2025年將佔38%的市場。這主要得益於強大的細胞農業Start-Ups生態系統、廣泛的創業投資支持以及美國食品藥物管理局(FDA)和農業部(USDA)的早期監管行動。該地區的成長也得益於對大型生產設施的大量投資、主要製造商持續開發商業工廠以及在餐飲服務管道開展的先導計畫,這些項目有助於驗證消費者對人造肉的接受度,並為人造肉的廣泛應用做好準備。
The Global Cultured Meat Market was valued at USD 1.2 billion in 2025 and is estimated to grow at a CAGR of 36.3% to reach USD 27.4 billion by 2035.

Cultured meat bioreactors are at the heart of the cultivated meat industry, providing scalable solutions for producing lab-grown meat without the need for animal slaughter. These bioreactors create precise environments for animal cell cultivation, enabling controlled growth, nutrient supply, and stress management. Different systems, including stirred-tank, perfusion, airlift, and hollow-fiber bioreactors, offer unique advantages for scalability and cell maintenance. Recent innovations in bioreactor design, culture media optimization, and scale-up techniques have improved cost efficiency, making mass production more feasible. Technological progress is expected to reduce production costs over time, increasing affordability and accessibility. Improved texture, flavor, and quality of cultivated meat will also drive consumer adoption, fueling market expansion. Growing ethical, environmental, and sustainability concerns, coupled with rising demand for meat alternatives, are key factors propelling this market.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $1.2 Billion |
| Forecast Value | $27.4 Billion |
| CAGR | 36.3% |
Sustainability is a central driver for the cultured meat bioreactors market. Lab-grown meat provides an environmentally friendly and ethical alternative to traditional meat production, aligning with changing consumer preferences. However, high initial capital and operational costs pose challenges, particularly for startups and emerging companies, slowing commercialization efforts despite strong market potential.
Ground and minced products accounted for a substantial share, valued at USD 901.8 million in 2025. These forms of cultured meat are leading the market due to their simpler production process and faster scalability compared with structured cuts. Their ease of tissue formation allows manufacturers to operate smaller bioreactors without compromising texture or sensory quality. Additionally, their versatility for popular applications such as burgers, meatballs, dumplings, and nuggets boosts consumer adoption. This compatibility enables producers to target high-volume segments that can absorb higher initial pricing while supporting predictable demand patterns.
The human food segment generated USD 841.7 million in 2025. The focus on human consumption drives much of the cultured-meat industry, as companies prioritize products aligned with mainstream diets and commercial foodservice demand. Pilot tastings, early regulatory approvals, and limited retail launches primarily target human consumption, allowing firms to validate taste, texture, and safety on a broader scale. This approach also aligns with sustainability and ethical protein trends, helping cultivated meat establish itself as a viable alternative to conventional animal products.
North America Cultured Meat Market captured 38% share in 2025, with the U.S. leading due to a strong ecosystem of cell-agriculture startups, extensive venture capital support, and initial regulatory engagement from the FDA and USDA. The region's growth is supported by substantial investments in large-scale production facilities, ongoing commercial plant developments by major manufacturers, and continued pilot projects in foodservice channels, which help confirm consumer acceptance and readiness for wider adoption.
Key players in the Global Cultured Meat Market include ABEC, Alfa Laval, Bioengineering AG, Eppendorf AG, Esco Lifesciences Group, GEA, Infors HT, INNOVA Bio-meditech, KBiotech GmbH, Merck KGaA, OLLITAL Technology, Pall Corporation, Sartorius AG, Solaris Biotech, and Vogtlin Instruments GmbH. Companies in the Global Cultured Meat Market are strengthening their foothold through strategic R&D investments to enhance bioreactor efficiency, scalability, and automation. Collaborations with research institutions and startups help accelerate technology development and optimize culture conditions. Expanding manufacturing capacities, developing cost-effective culture media, and offering turnkey solutions for pilot and commercial-scale production enhance market presence. Firms are also diversifying product portfolios to address specific applications in cellular agriculture and cultivated meat production. Regulatory engagement, participation in industry consortia, and sustainability initiatives further reinforce credibility and position companies as leaders in this emerging market.